IDT Biologika is a biopharmaceutical contract development and manufacturing organization with more than 100 years of experience in the production of biological products. The company provides integrated development and manufacturing services for antibodies, vaccines, gene and immune therapeutics, and other biological modalities. Capabilities span upstream processing using single‑use bioreactors and fixed‑bed or stirred‑tank systems, as well as downstream operations including scalable chromatography, filtration, and formulation development. Automated aseptic fill‑finish for vials and syringes supports both clinical and commercial supply. Comprehensive in‑house analytical methods, covering molecular, microbiological, biochemical, and physical testing, enable method development, validation, and batch release within a unified quality framework. IDT Biologika’s infrastructure supports technology transfer, process characterization, and GMP‑compliant manufacturing across a wide range of scales. This combination of modular technologies and multimodal expertise allows the systematic development, production, and quality control of complex biologics throughout their life cycle.